Wound Treatments in Belgium

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN BELGIUM
• Executive Summary
• Another Good Year for OTC
• Despite A Still Unfavourable Context
• Almost All Sectors Benefit From An Improvement
• Some Players More Dynamic Than Others in A Highly Fragmented Competitive Environment
• Slightly Better Fate Anticipated
• Key Trends and Developments
• Local Policy Still Strongly Impacts OTC Sales
• Possible Lower Pressure Regarding Switches and Distribution
• Economic Development Should Be More Favourable
• the Quest of Longevity and Health and Wellness Fuels Vds
• Is the Success of Functional Food and Beverage and Some Cosmetic & Toiletries A Threat Or An Opportunity?
• Increasingly Tough and Maybe Less Fragmented Competitive Environment
• Appendix
• OTC Registration and Classification
• De-listing Or De-reimbursement
• Advertising
• Packaging and Labelling
• Distribution
• Vitamins & Dietary Supplements Registration and Classification
• Generics
• Appendix
• Consumer Expenditure on Health Goods and Medical Services
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
• Market Indicators
  • Table 2 Life Expectancy at Birth 2001-2006
• Market Data
  • Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
  • Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
  • Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
  • Table 7 Penetration of Private Label by Sector 2002-2006
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
• Definitions
• Sources
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - BELGIUM
• Arkopharma Belux SA
• Strategic Direction
• Key Facts
  • Summary 2 Arkopharma Belux SA: Key Facts
  • Summary 3 Arkopharma Belux SA: Operational Indicators
• Company Background & Production
  • Summary 4 Arkopharma Belux SA: Production Statistics 2005
• Competitive Positioning
  • Summary 5 Arkopharma Belux SA: Competitive Position 2006
• Biodynamics NV
• Strategic Direction
• Key Facts
  • Summary 6 Biodynamics BVBA: Key Facts
• Company Background & Production
  • Summary 7 Biodynamics BVBA: Production Statistics 2006
• Competitive Positioning
  • Summary 8 Summary Biodynamics BVBA: Competitive Position 2006
• Omega Pharma NV
• Strategic Direction
• Key Facts
  • Summary 9 Omega Pharma Belgium NV: Key Facts
  • Summary 10 Omega Pharma Belgium NV: Operational Indicators
• Company Background
• Production
  • Summary 11 Omega Pharma Belgium NV: Production Statistics 2004-2005
• Competitive Positioning
  • Summary 12 Summary Omega Pharma Belgium NV: Competitive Position 2006
• Patch Pharma SA
• Strategic Direction
• Key Facts
  • Summary 13 Patch Pharma NV SA: Key Facts
• Company Background & Production
• Competitive Positioning
• Vemedia Pharma NV
• Strategic Direction
• Key Facts
  • Summary 14 Vemedia Pharma NV: Key Facts
• Company Background
• Production
  • Summary 15 Vemedia Pharma NV: Production Statistics 2005
• Competitive Positioning
  • Summary 16 Summary Vemedia Pharma NV: Competitive Position 2006
• WOUND TREATMENTS IN BELGIUM
• Overview
• Sector Data
  • Table 12 Sales of Wound Treatments by Subsector: Value 2001-2006
  • Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
  • Table 14 Wound Treatments Company Shares by Retail Value 2002-2006
  • Table 15 Wound Treatments Brand Shares by Retail Value 2003-2006
  • Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
  • Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
• Wound treatments Belgium